Medical Specialties News
-
Imperative Care Announces FDA Clearance of Initial Products
Imperative Care, Inc., a company singularly dedicated to finding answers to unsolved problems in stroke, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its first family of access catheters, designed to deliver interventional treatments during minimally invasive neurovascular procedures for aneurysms, stroke and other brain blood vessel conditions. “Recognizing ...
-
Sofregen Receives 510(k) Clearance for Silk Voice - The First and Only Natural Silk Protein Injectable Product for Tissue Bulking
Sofregen Medical, Inc. (Sofregen), an early stage commercial biotechnology company developing products for medical aesthetics and reconstructive surgery, announced today that Silk Voice has been cleared by the U.S. Food and Drug Administration (FDA) for augmenting vocal fold tissue for phonation improvement. This is the first and only FDA cleared product made from solubilized silk protein and is ...
-
Fibralign Awarded SBIR Phase IIS from Department of Defense
Fibralign announced today that it has been awarded a Small Business Innovation Research (SBIR) Sequential Phase II (Phase IIS) from the Department of Defense (DoD) Defense Health Program (DHP). This two-year grant provides $996,609 in funding to continue advancing Fibralign’s development of a novel treatment of volumetric muscle loss. Project Title: Aligned ...
-
Aurobindo Pharma’s subsidiary Acrotech Biopharma to acquire portfolio of seven marketed oncology injectable products from Spectrum Pharmaceuticals
Hyderabad, India, 17th January 2019: Aurobindo Pharma Limited (BSE: 524804 and NSE: AUROPHARMA) ("Aurobindo"), announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also brings-in an experienced branded commercial infrastructure in the US. Acrotech Biopharma LLC ...
-
Cannabis Sequencing and New Cancer Research
In 2014, the entire genome of Cannabis stavia L. was sequenced. This news received national attention with eye-catching headlines such as: “Marijuana Genome Sequenced for Health, Not Highs”. Researchers and oncologists took note, not due to the attention-grabbing headlines, but because their focus was to pair the decoded cannabis genome research with sequencing of the ...
-
Nature communications. ATP released by intestinal bacteria limits…
T cell dependent secretory IgA (SIgA) generated in the Peyer’s patches (PPs) of the small intestine shapes a broadly diverse microbiota that is crucial for host physiology. The mutualistic co-evolution of host and microbes led to the relative tolerance of host’s immune system towards commensal microorganisms. The ATP-gated ionotropic P2X7 receptor limits T follicular helper (Tfh) ...
-
Memic Performs First Israel Case in Transvaginal Hysterectomy Study
Memic has successfully completed the first case in its Israeli study of transvaginal hysterectomy using the company’s innovative hominis® robotic-assisted surgical platform. The procedure was performed by Prof. Lior Lowenstein of Haifa’s Rambam Healthcare Campus. According to Prof. Lowenstein, “This innovative surgical procedure should replace most of the gynecological ...
-
The Importance of DNA Sequencing and Cancer Research
In the simplest of terms, DNA, or deoxyribonucleic acid, is the genetic code that determines all the characteristics of a living thing. This double, long chain of molecules called nucleotides tell each cell what proteins to make, giving them the genetic instruction guide for life and its processes. Each cell’s development, reproduction and death are controlled by the ...
-
Microneedle patch technology shows potential for long-acting contraception
ATLANTA, January 14, 2019 – The laboratory of Prof. Mark Prausnitz at Georgia Tech developed dissolving microneedle patches that administer a long-acting contraceptive for more than 30 days using microneedle technology licensed exclusively to Micron Biomedical. This work was published in the journal Nature Biomedical Engineering on January 14, 2019. In the study conducted in animals, ...
-
Fibralign receives ISO 13485:2016 upgrade certification
Fibralign received Certification Notification on January 21, 2019 from DEKRA Certification B. V. that the Company’s management system meets the requirements of EN ISO 13486:2016. This internationally agreed standard sets out the requirements for a quality management system specific to the medical devices industry. ISO 13485:2016 is designed to respond to the latest quality management ...
-
SafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath
Jan 11, 2019 –SafeHeal, an innovator in the field of digestive surgery, has concluded its first-in-human clinical study for its novel Colovac bypass sheath in patients undergoing colorectal surgery. The single-arm 15-patient study was aimed at evaluating the safety and efficacy of Colovac in the protection of colorectal anastomosis in adult patients who were scheduled to ...
By SafeHeal
-
Multiple Publications and Presentations Underscore Seno Medical’s Value Proposition in Mitigating the Cost and Burden of Unnecessary Breast Biopsies
Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using opto-acoustic ultrasound (OA/US) imaging to differentiate benign from malignant masses, today provided a summary of key 2018 data publications and presentations that demonstrate the clinical utility and healthcare economic benefits of its proprietary, cutting-edge technology. ...
-
FierceHealthcare Names Gauss Surgical as One of Its 2019 “Fierce 15” Companies
Gauss Surgical today announced that it has been named by FierceHealthcare as one of the 2019 Fierce 15 companies, designating it as one of the most promising healthcare companies in the industry. Gauss Surgical is an AI-driven healthcare technology company that is evolving the delivery model for medical devices and services in hospitals. The company’s flagship product, Triton, monitors ...
-
CBD May Slow Cancer Growth
According to the American Cancer Society, scientists have recently reported that THC and other cannabinoids such as CBD slow growth and/or cause death in certain types of cancer cells growing in lab dishes. This is not only fascinating, but encouraging news for not only researchers, but those who are diagnosed with cancer, or have a loved one who has cancer. Additionally, some animal studies ...
-
S1 Biopharma To Participate In Panel Discussion On Investment Opportunities In China Hosted By Duane Morris And The Chinese Biopharmaceutical Association
New York, NY – Jan. 4, 2019 – S1 Biopharma, Inc. (S1) announced today that the company will participate in a panel discussion, “Innovation Across Borders: Strategies for U.S. and Chinese Companies in the Health Sciences Industry,” to be hosted by Duane Morris LLP and the Chinese Biopharmaceutical Association (USA) on Tuesday, January 8, 2019 in San Francisco, CA. The ...
-
S1 Biopharma Announces Expanded Analysis Of Phase 2A Data On Lorexys™ For Treatment Of Hypoactive Sexual Desire Disorder Based On Pgic Scale To Be Presented At 2019 Isswsh/Issm Joint Meeting
New York, NY – Jan. 4, 2019 – S1 Biopharma, Inc. (S1) announced today that researchers will present an expanded analysis of data from the company’s Phase 2a clinical trial of Lorexys™ for the treatment of women with hypoactive sexual desire disorder (HSDD) based on the Patient Global Impression of Change (PGIC) scale. Robert E. Pyke, MD, PhD, president of Pykonsult, LLC, ...
-
Current Treatment Options and Research for Glioblastoma
Glioblastoma originates in the brain and typically does not spread to other parts of the body. It is a particularly difficult cancer to treat because tumors often overlap with healthy brain tissue making full surgical removal usually impossible. Treatments such as chemotherapy and radiation may slow the disease’s progression, but there is currently no cure. Glioblastoma Multiforme is the ...
-
Lite-Med Participated In the Asian Urological Medicine Association In Cambodia
Lite-Med collaborated with UAA and shared the case study results of LM-9200ELMA and LM-IASO at conference of urological disease treatment using extracoporeal shock wave lithotripsy (ESWL) at Royal Phnom Penh Hospital, Cambodia, January 2019. The case studies were presented by Prof. Allen W. Chiu (Taiwan), Prof. Edward CS Chen and Prof. Hung-Jen ...
By Lite-Med Inc
-
Endotronix Hires Industry Veteran Jim Yearick as Senior Vice President of Sales and Marketing
Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced that industry veteran Jim Yearick has joined the executive leadership team as Senior Vice President of Sales and Marketing. Mr. Yearick will oversee Endotronix’s worldwide sales and marketing efforts for the Cordella™ Heart Failure System (Cordella ...
-
BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment
BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it has received FDA clearance to include additional language in its product’s Indications for Use (IFU), adding key terminology related to “multi-modal, multi-parameter assessment" of “concussion" and “mild Traumatic Brain ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you